Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation

gan Kornblit, Brian, Chen, Yun, Sandmaier, Brenda M.
Cyhoeddwyd 2012

Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation

gan Kornblit, Brian, Leisenring, Wendy M., Santos, Erlinda B., Storb, Rainer, Sandmaier, Brenda M.
Cyhoeddwyd 2013

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

gan Kornblit, Brian, Munthe-Fog, Lea, Madsen, Hans O, Strøm, Jens, Vindeløv, Lars, Garred, Peter
Cyhoeddwyd 2008

Toll like receptor polymorphisms in allogeneic hematopoietic cell transplantation

gan Kornblit, Brian, Enevold, Christian, Wang, Tao, Spellman, Stephen, Haagenson, Mike, Lee, Stephanie J, Müller, Klaus
Cyhoeddwyd yn Biol Blood Marrow Transplant (2014)

Immunomodulatory effects induced by CTLA4-Ig with donor PBMC infusion in canine MHC-haploidentical nonmyeloablative hematopoietic cell transplantation

gan Chen, Yun, Fukuda, Takahiro, Thakar, Monica S., Kornblit, Brian T., Storer, Barry E., Santos, Erlinda B., Storb, Rainer, Sandmaier, Brenda M.
Cyhoeddwyd 2011

Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney conce...

gan Wilbur, D. Scott, Chyan, Ming-Kuan, Nakamae, Hirohisa, Chen, Yun, Hamlin, Donald K., Santos, Erlinda B., Kornblit, Brian T., Sandmaier, Brenda M.
Cyhoeddwyd 2012

Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211–labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation

gan Chen, Yun, Kornblit, Brian, Hamlin, Donald K., Sale, George E., Santos, Erlinda B., Wilbur, D. Scott, Storer, Barry E., Storb, Rainer, Sandmaier, Brenda M.
Cyhoeddwyd 2012

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

gan Kornblit, Brian, Wang, Tao, Lee, Stephanie J., Spellman, Stephen R., Zhu, Xiaochun, Fleischhauer, Katharina, Müller, Carlheinz, Verneris, Michael R., Müller, Klaus, Johansen, Julia S., Vindelov, Lars, Garred, Peter
Cyhoeddwyd yn Bone Marrow Transplant (2016)

(GT)(n) Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

gan Køllgaard, Tania, Kornblit, Brian, Petersen, Jesper, Klausen, Tobias Wirenfeldt, Mortensen, Bo Kok, Brændstrup, Peter, Sengeløv, Henrik, Høgdall, Estrid, Müller, Klaus, Vindeløv, Lars, Andersen, Mads Hald, thor Straten, Per
Cyhoeddwyd yn PLoS One (2016)

Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation

gan Minculescu, Lia, Fischer-Nielsen, Anne, Haastrup, Eva, Ryder, Lars Peter, Andersen, Niels Smedegaard, Schjoedt, Ida, Friis, Lone Smidstrup, Kornblit, Brian Thomas, Petersen, Søren Lykke, Sengelov, Henrik, Marquart, Hanne Vibeke
Cyhoeddwyd yn Front Immunol (2020)

Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Ste...

gan Minculescu, Lia, Marquart, Hanne Vibeke, Ryder, Lars Peter, Andersen, Niels Smedegaard, Schjoedt, Ida, Friis, Lone Smidstrup, Kornblit, Brian Thomas, Petersen, Søren Lykke, Haastrup, Eva, Fischer-Nielsen, Anne, Reekie, Joanne, Sengelov, Henrik
Cyhoeddwyd yn Front Immunol (2019)

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

gan Kornblit, Brian, Storer, Barry E., Andersen, Niels S., Maris, Michael B., Chauncey, Thomas R., Petersdorf, Effie W., Woolfrey, Ann E., Flowers, Mary E. D., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Cyhoeddwyd yn Blood (2020)

Fludarabine/2 Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related HCT: A Phase III Randomized Trial

gan Kornblit, Brian, Maloney, David G., Storb, Rainer, Storek, Jan, Hari, Parameswaran, Vucinic, Vladan, Maziarz, Richard T., Chauncey, Thomas R., Pulsipher, Michael A., Bruno, Benedetto, Petersen, Finn B., Bethge, Wolfgang A., Hübel, Kai, Bouvier, Michelle E., Fukuda, Takahiro, Storer, Barry E., Sandmaier, Brenda M.
Cyhoeddwyd 2013

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

gan Kornblit, Brian, Maloney, David G., Storer, Barry E., Maris, Michael B., Vindeløv, Lars, Hari, Parameswaran, Langston, Amelia A., Pulsipher, Michael A., Bethge, Wolfgang A., Chauncey, Thomas R., Lange, Thoralf, Petersen, Finn B., Hübel, Kai, Woolfrey, Ann E., Flowers, Mary E.D., Storb, Rainer, Sandmaier, Brenda M.
Cyhoeddwyd 2014

Effectiveness of addition of sirolimus to cyclosporine and mycophenolate mofetil-based graft-versus-host disease prophylaxis after unrelated nonmyeloablative hematopoietic cell tra...

gan Sandmaier, Brenda M., Kornblit, Brian, Storer, Barry E., Olesen, Gitte, Maris, Michael B., Langston, Amelia A., Gutman, Jonathan A., Petersen, Soeren L., Chauncey, Thomas R., Bethge, Wolfgang A., Pulsipher, Michael A., Woolfrey, Ann E., Mielcarek, Marco, Martin, Paul J., Appelbaum, Fred R., Flowers, Mary E.D., Maloney, David G., Storb, Rainer
Cyhoeddwyd yn Lancet Haematol (2019)